Vonderheid E C, Suhadolnik R J, Sobel E L, Flick M B, Mosca J D
Clin Immunol Immunopathol. 1984 Apr;31(1):138-50. doi: 10.1016/0090-1229(84)90199-5.
The activity of the interferon-induced enzyme 2',5'-oligoadenylate synthetase (2',5' An synthetase) was found to be increased in the lysates of peripheral blood mononuclear leukocytes obtained from 10 of 25 (40%) patients with cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). A positive association was found between the level of mean total synthetase activity and extent of involvement (stage) of disease. However, the leukocytes from two patients with relatively high proportions of neoplastic T-cells in the blood (Sézary syndrome) had negligible enzyme activity. It is speculated that increased interferon production in vivo may account for the observed enzyme changes in normal blood leukocytes from these patients, and that the neoplastic T-cell population is the most likely source of the presumed interferon production. Possible mechanisms and biologic consequences of high levels of endogenous interferon in patients with cutaneous T-cell lymphoma are discussed.
在25例皮肤T细胞淋巴瘤(蕈样肉芽肿和Sezary综合征)患者中,有10例(40%)外周血单个核白细胞裂解物中的干扰素诱导酶2',5'-寡腺苷酸合成酶(2',5' An合成酶)活性升高。平均总合成酶活性水平与疾病累及范围(分期)之间存在正相关。然而,两名血液中肿瘤性T细胞比例相对较高的患者(Sezary综合征)的白细胞酶活性可忽略不计。据推测,体内干扰素产生增加可能是这些患者正常血液白细胞中观察到的酶变化的原因,并且肿瘤性T细胞群体最有可能是假定的干扰素产生来源。讨论了皮肤T细胞淋巴瘤患者内源性干扰素水平升高的可能机制和生物学后果。